The relationship between tumor necrosis factor-α, brain natriuretic peptide and atrial natriuretic peptide in patients with chronic heart failure

International Journal of Cardiology

Volumn 141, Issue 1, 2010, Pages 39-43

  Vaz Pérez, Amalia ^a   Doehner, Wolfram ^a   von Haehling, Stephan ^a   Schmidt, Hendrik ^b   Zimmermann, Arabel V ^a   Volk, Hans Dieter ^a   Anker, Stefan D ^a   Rauchhaus, Mathias ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Cardiac cachexia; Chronic heart failure; Cytokines; Natriuretic peptides

Indexed keywords

ADRENALIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA; URIC ACID;

AGE; AGED; ARTICLE; BLOOD SAMPLING; CACHEXIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CREATININE CLEARANCE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HUMAN; MALE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN SECRETION; VENOUS BLOOD;

AGE FACTORS; AGED; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CACHEXIA; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION;

EID: 77951666444     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.11.146     Document Type: Article

References (28)

1. Birkenfeld A.L., Budziarek P., Boschmann M., et al. Atrial natriuretic peptide induces postprandial lipid oxidation in man. Diabetes (2008)
2. Burnett Jr. J.C., Kao P.C., Hu D.C., et al. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 231 4742 (1986) 1145-1147
3. Cody R.J., Atlas S.A., Laragh J.H., et al. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest 78 (1986) 1362-1374
4. Raine A.E., Erne P., Burgisser E., et al. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 315 (1986) 533-537
5. Nakaoka H., Imataka K., Amano M., Fujii J., Ishibashi M., and Yamaji T. Plasma levels of atrial natriuretic factor in patients with congestive heart failure. N Engl J Med 313 (1985) 892-893
6. Leinonen H., Naveri H., Tikkanen I., Sovijarvi A., and Fyhrquist F. Basal and exercise plasma levels of atrial natriuretic factor in congestive heart failure. Am Heart J 116 (1988) 209-211
7. Schiffrin E.L., and Taillefer R. Correlation of left ventricular ejection fraction and plasma atrial natriuretic peptide in congestive heart failure. N Engl J Med 315 (1986) 765-766
8. Gottlieb S.S., Kukin M.L., Ahern D., and Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 13 (1989) 1534-1539
9. Omland T., Aakvaag A., Bonarjee V.V., et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N- terminal proatrial natriuretic peptide. Circulation 93 (1996) 1963-1969
10. Cowie M.R., Struthers A.D., Wood D.A., et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350 (1997) 1349-1353
11. Maisel A., Mueller C., Adams Jr. K., et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 10 (2008) 824-839
12. Anker S.D., Chua T.P., Ponikowski P., et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96 (1997) 526-534
13. Anker S.D., Negassa A., Coats A.J., et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361 (2003) 1077-1083
14. Anker S.D., Swan J.W., Volterrani M., et al. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J 18 (1997) 259-269
15. Anker S.D., Chua T.P., Ponikowski P., et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96 (1997) 526-534
16. Torre-Amione G., Kapadia S., Benedict C., Oral H., Young J.B., and Mann D.L. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 27 (1996) 1201-1206
17. van Veldhuisen D.J., Boomsma F., de Kam P.J., et al. Influence of age on neurohormonal activation and prognosis in patients with chronic heart failure. Eur Heart J 19 (1998) 753-760
18. Davis K.M., Fish L.C., Elahi D., Clark B.A., and Minaker K.L. Atrial natriuretic peptide levels in the prediction of congestive heart failure risk in frail elderly. JAMA 267 (1992) 2625-2629
19. Anker S.D., Ponikowski P., Varney S., et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349 (1997) 1050-1053
20. Levine B., Kalman J., Mayer L., Fillit H.M., and Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323 (1990) 236-241
21. Liu S.F., and Malik A.B. NF-kappa B activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol 290 (2006) L622-L645
22. Siednienko J., Jankowska E.A., Banasiak W., Gorczyca W.A., and Ponikowski P. Nuclear factor-kappaB activity in peripheral blood mononuclear cells in cachectic and non-cachectic patients with chronic heart failure. Int J Cardiol 122 (2007) 111-116
23. Sharma R., Bolger A.P., Rauchhaus M., et al. Cellular endotoxin desensitization in patients with severe chronic heart failure. Eur J Heart Fail 7 (2005) 865-868
24. Ladetzki-Baehs K., Keller M., Kiemer A.K., et al. Atrial natriuretic peptide, a regulator of nuclear factor-kappaB activation in vivo. Endocrinology 148 (2007) 332-336
25. Kiemer A.K., and Vollmar A.M. Autocrine regulation of inducible nitric-oxide synthase in macrophages by atrial natriuretic peptide. J Biol Chem 273 (1998) 13444-13451
26. Birkenfeld A.L., Boschmann M., Moro C., et al. Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans. J Clin Endocrinol Metab 90 (2005) 3622-3628
27. Rauchhaus M., Doehner W., Francis D.P., et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102 (2000) 3060-3067
28. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150